title: Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.
abstract: A family is described with two siblings who suffered at different times from a single episode of meningococcal meningitis by Neisseria meningitidis groups B and C, respectively. In the two subjects, hemolytically active fifth component of complement (C5) was not detectable and antigenic C5 was less than 0.05% and less than 0.7% of normal, respectively. Repletion of sera by purified human C5 (70 micrograms/ml) restored total complement hemolytic activities. The asymptomatic first degree family members had C5 levels compatible with a heterozygous state of C5 deficiency. C4 allotyping revealed an inherited partial deficiency (Q0) of C4A and C4B in the family with a combined C4AQ0 and C4BQ0 heterozygous condition in one and C4BQ0 heterozygosity in the other C5 deficient (C5D) subject. To our knowledge, this is the first human kindred with recognized combined C5 and C4 deficiency. No other defect of the humoral and cellular immune system was found in this family, including specific immune response to tetravalent meningococcal vaccine. The effect of partial C4 deficiency on classical pathway function was assessed by inhibition of immune precipitation (IIP) of forming bovine serum albumin (BSA)/anti-BSA immune complexes. Sera from all family members showed normal IIP values, with exception of the subject with combined partial deficiency in C4A, C4B, and complete deficiency in C5. Despite undetectable functional C5 in the C5D sera, the titration of the alternative pathway indicated intact but deficient hemolytic activities when rabbit erythrocytes (EC) were used as indicator cells in the presence of Mg2+ and EGTA in an end-point or kinetic assay. Preincubation of the two sera at 0 degrees C for 60 min with rabbit ECs reduced alternative pathway hemolytic activity by 24 and 100%, respectively. When rabbit ECs were replaced by guinea pig ECs no alternative pathway function could be measured. The results indicate that the apparent functional activity of the alternative pathway in C5D sera strongly depends on a factor(s) present in such serum and/or on the detection system used. We conclude that the two C5D individuals of the family reported here may not have sufficient C5 activity to provide efficient protection against Neisserial infections in conditions where complement functions beyond C3 opsonic activity are required in vivo.
authors.affiliation: Department of Pediatrics, University Hospital, Lausanne, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Gianella-Borradori
authors.forename: L
authors.initials: L
authors.lastname: Borradori
authors.forename: P M
authors.initials: PM
authors.lastname: Schneider
authors.forename: E
authors.initials: E
authors.lastname: Gautier
authors.forename: P J
authors.initials: PJ
authors.lastname: Späth
mesh_terms: D000293:Adolescent; D000328:Adult; D003167:Complement Activation; D003181:Complement C4 / Q000172:deficiency* / Q000235:genetics; D003182:Complement C5 / Q000172:deficiency* / Q000235:genetics; D005260:Female; D006801:Humans; D007126:Immunoglobulin Allotypes; D008297:Male; D010375:Pedigree
chemical_list: D003181:Complement C4; D003182:Complement C5; D007126:Immunoglobulin Allotypes